BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 12773883)

  • 1. [Recent neuropathology of parkinsonian syndromes].
    Duyckaerts C; Verny M; Hauw JJ
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S11-8. PubMed ID: 12773883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of alpha-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex.
    Sebeo J; Hof PR; Perl DP
    Acta Neuropathol; 2004 Jun; 107(6):497-503. PubMed ID: 15024581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of disorders with synuclein pathology and parkinsonism.
    Farrer M; Gwinn-Hardy K; Hutton M; Hardy J
    Hum Mol Genet; 1999; 8(10):1901-5. PubMed ID: 10469843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease and parkinsonism: neuropathology.
    Dickson DW
    Cold Spring Harb Perspect Med; 2012 Aug; 2(8):. PubMed ID: 22908195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
    Yokota O; Terada S; Ishizu H; Tsuchiya K; Kitamura Y; Ikeda K; Uéda K; Kuroda S
    Acta Neuropathol; 2002 Oct; 104(4):333-41. PubMed ID: 12200618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degenerative axonal changes in the hippocampus and amygdala in Parkinson's disease.
    Bertrand E; Lechowicz W; Lewandowska E; Szpak GM; Dymecki J; Kosno-Kruszewska E; Wierzba-Bobrowicz T
    Folia Neuropathol; 2003; 41(4):197-207. PubMed ID: 14977249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration.
    Yazawa I; Giasson BI; Sasaki R; Zhang B; Joyce S; Uryu K; Trojanowski JQ; Lee VM
    Neuron; 2005 Mar; 45(6):847-59. PubMed ID: 15797547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification.
    Hishikawa N; Hashizume Y; Ujihira N; Okada Y; Yoshida M; Sobue G
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):280-7. PubMed ID: 12787325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autosomal recessive juvenile parkinsonism: its pathogenesis is involved in the ubiquitin-proteasome pathway].
    Hattori N; Shimura H; Kubo S; Suzuki T; Tanaka K; Mizuno Y
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1293-6. PubMed ID: 11464483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia.
    Yancopoulou D; Xuereb JH; Crowther RA; Hodges JR; Spillantini MG
    J Neuropathol Exp Neurol; 2005 Mar; 64(3):245-53. PubMed ID: 15804056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
    Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S
    J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy bodies in progressive supranuclear palsy.
    Mori H; Oda M; Komori T; Arai N; Takanashi M; Mizutani T; Hirai S; Mizuno Y
    Acta Neuropathol; 2002 Sep; 104(3):273-8. PubMed ID: 12172913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.